Best in class urologic surgical outcomes.

Urologic centers of excellence produce superior outcomes

Hackensack University Medical Center has three Urologic Centers of Excellence in Prostate, Kidney and Bladder Cancers.

Prostate Kidney and Bladder Cancer-Best In Class Outcomes

 

Prostate Cancer

Hackensack University Medical Center urologists are pioneers in prostate cancer care and are internationally recognized leaders in robotic prostate cancer surgery. Additionally, our surgeons are among a select few worldwide using the da Vinci SP® single port robotic system to perform complex prostate cancer surgeries through a one-inch incision. As the highest volume prostate cancer institute in New Jersey, Hackensack has earned the Gold Seal of Approval by the Joint Commission.

Exceptional outcomes include:

Prostate Cancer Data

  • 1,833 new patients with advanced disease treated & managed by John Theurer Cancer Center at Hackensack University Medical Center
  • 1500 robotic prostatectomies in 5 years
  • Average length of stay
  • ALOS 1.28 v ELOS 1.83
  • 0% mortality
  • Readmission of 1.93% vs. Expected Readmission of 3.4% (2019)

Kidney Cancer

Hackensack University Medical Center is home to internationally recognized kidney cancer surgeons who have pioneered advanced robotic surgical techniques including selective clamping, retroperitoneal approach, 3D intra-operative imaging, near infrared fluorescence imaging and single port surgery that allow us to treat kidney tumors while sparing healthy kidney tissue in the safest and least invasive way while maximizing kidney function.

Our full team is comprised of radiologists, pathologists, medical oncologists, and urologic surgeons offering the latest diagnostic and treatment options. Together, our specialists have published more than 50 papers on kidney cancer management that documents some of the best outcomes in the field, including:

Kidney Cancer Data

  • 590 robotic kidney procedures 2018-2019
  • Length of Stay
    ALOS 2.3 vs. ELOS of 3.33 (2019)
  • Mortality
    Actual 0% vs. Expected 0.49% (2019)
  • Readmission
    Actual readmission of 2.8% vs. Expected 4.8% (2019)

Bladder Cancer

Hackensack University Medical Center’s robotic urologic surgeons are among some of the most experienced in the United States.

A full 100% of bladder cancer surgeries, including lymph node removal, partial and total bladder removal and bladder reconstruction, are performed robotically.

In addition to developing new robotic surgical techniques, our bladder cancer specialists have also developed protocols to educate patients and prepare them for surgery, improve patient safety and promote a faster recovery. Our Enhanced Recovery After Surgery (ERAS) protocol, for example, helps patients learn to urinate in a new way and cope with common symptoms that occur as their bodies adjust to their reconstructed bladder. As a result, Hackensack achieves outstanding patient outcomes, including:

Bladder Cancer Data

  • Length of stay
  • 6-7 days (2019) (reduced from 8-9 days – 2018)
  • Mortality
  • 0% (2019) vs Expected .045%

Readmission

  • 11% vs expected 19.75% (2019)
X
We use cookies to improve your site experience. By using this site,
you agree to our Terms & Conditions. Also, please read our Privacy Policy.
Accept All Cookies